Genelux Common Stock Retained Earnings
| GNLX Stock | 2.63 0.21 8.68% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Genelux Common's long-term financial health and intrinsic value.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Genelux Common Company Retained Earnings Analysis
Genelux Common's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Genelux Common Retained Earnings | (251.39 M) |
Most of Genelux Common's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genelux Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
| Competition |
Based on the latest financial disclosure, Genelux Common has a Retained Earnings of (251.39 Million). This is 126.99% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The retained earnings for all United States stocks is 102.69% higher than that of the company.
Genelux Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Genelux Common's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Genelux Common could also be used in its relative valuation, which is a method of valuing Genelux Common by comparing valuation metrics of similar companies.Genelux Common is currently under evaluation in retained earnings category among its peers.
Genelux Fundamentals
| Return On Equity | -1.31 | ||||
| Return On Asset | -0.63 | ||||
| Current Valuation | 69.87 M | ||||
| Shares Outstanding | 37.6 M | ||||
| Shares Owned By Insiders | 12.32 % | ||||
| Shares Owned By Institutions | 13.08 % | ||||
| Number Of Shares Shorted | 2.3 M | ||||
| Price To Book | 3.76 X | ||||
| Price To Sales | 12,362 X | ||||
| Revenue | 8 K | ||||
| Gross Profit | 8 K | ||||
| EBITDA | (28.97 M) | ||||
| Net Income | (29.87 M) | ||||
| Total Debt | 1.87 M | ||||
| Book Value Per Share | 0.77 X | ||||
| Cash Flow From Operations | (21.23 M) | ||||
| Short Ratio | 10.32 X | ||||
| Earnings Per Share | (0.95) X | ||||
| Target Price | 18.0 | ||||
| Number Of Employees | 24 | ||||
| Beta | -0.39 | ||||
| Market Capitalization | 109.05 M | ||||
| Total Asset | 34.72 M | ||||
| Retained Earnings | (251.39 M) | ||||
| Working Capital | 24.64 M | ||||
| Net Asset | 34.72 M |
About Genelux Common Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Genelux Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genelux Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genelux Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Genelux Stock Analysis
When running Genelux Common's price analysis, check to measure Genelux Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genelux Common is operating at the current time. Most of Genelux Common's value examination focuses on studying past and present price action to predict the probability of Genelux Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genelux Common's price. Additionally, you may evaluate how the addition of Genelux Common to your portfolios can decrease your overall portfolio volatility.